다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Lixte Biotechnology Holdings Inc (LIXT)
Lixte Biotechnology Holdings Inc (LIXT) 뉴스

LIXT

Lixte Biotechnology (LIXT)

Lixte Biotechnology Holdings Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:LIXT

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/04	21:30	GlobeNewswire Inc.	LIXTE Receives U.S. Patent Issue Notification for Immune Oncology	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/08/27	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/08/26	21:30	GlobeNewswire Inc.	First Patient Dosed with LIXTE’s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/08/24	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/08/20	06:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/08/19	21:30	GlobeNewswire Inc.	LIXTE Biotechnology Provides Update On Recent Activities and Developments	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/08/15	21:30	GlobeNewswire Inc.	LIXTE Biotechnology Holdings to Present at Two Investor Conferences	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/08/09	05:06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/08/02	05:05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/07/13	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/07/12	02:55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/06/15	00:00	GlobeNewswire Inc.	LIXTE Biotechnology Holdings announces collaboration on a New Colon Cancer Clinical Trial	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/06/14	22:30	GlobeNewswire Inc.	LIXTE Biotechnology Holdings to Collaborate with Roche and Netherlands Cancer Institute in New Colon Cancer Clinical Trial	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/06/06	21:30	GlobeNewswire Inc.	Scientific Journal Reports Findings that Show LIXTE’s Lead Clinical Compound, LB-100, Increases Recognition of Colon Cancer Cells by the Immune System	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/06/03	21:30	GlobeNewswire Inc.	LIXTE Biotechnology Holdings Names Distinguished Oncologist Jan Schellens as Chief Medical Officer	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/05/08	22:25	GlobeNewswire Inc.	LIXTE Biotechnology Co-Sponsoring International Scientific Conference on “Therapeutic Over-Activation in Cancer”	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/04/25	04:25	AllPennyStocks.com	Mixed Shelf Filing Gives Micro Cap Delayed Boost	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/03/28	04:35	AllPennyStocks.com	Biotech Steals The Show Following Pre-Clinical Data Announcement	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/03/27	21:30	GlobeNewswire Inc.	NEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD CLINICAL COMPOUND, CAN FORCE CANCER CELLS TO GIVE UP THEIR CANCER-CAUSING PROPERTIES	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/03/21	21:30	GlobeNewswire Inc.	LIXTE Provides Update on Progress with LB-100 as a PP2A Inhibitor to Enhance Chemotherapy and Immunotherapy Cancer Treatments	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/02/28	06:59	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/02/27	22:30	GlobeNewswire Inc.	Professor René Bernards to Present New Pre-Clinical Data on LIXTE’s LB-100 at Joint Conference of European and American Associations for Cancer Research	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/02/27	00:48	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/02/26	22:30	GlobeNewswire Inc.	LIXTE Biotechnology Enters into Exclusive Immune Oncology Patent License Agreement with NINDS and NCI	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2024/01/29	22:30	GlobeNewswire Inc.	First Patient Dosed with LIXTE’s LB-100 and GSK’s Immunotherapy Dostarlimab-gxly in Ovarian Clear Cell Carcinoma Trial	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/11/29	07:21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/11/14	04:28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/11/13	22:30	GlobeNewswire Inc.	LIXTE Biotechnology Provides Update on Clinical Progress and Expanding Collaborations	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/11/10	07:16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc
2023/10/18	06:27	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc

검색 관련기사 보기:NASDAQ:LIXT

1 2 3 4 5 6 7 다음 >>

US Dollar vs Sterling

American Express

Gold vs US Dollar

Financial Select Sector

Health Care Select Sector

JP Morgan Chase

Deutsche Telekom (QX)

US Dollar vs Euro

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관